Company profile
Vexev
Vexev develops VxWave, a robotic tomographic ultrasound platform that automates upper-limb vascular imaging for dialysis and other vascular-care workflows....
Facts
- Segment
- HEALTHCARE
- Country
- AU
- Headquarters
- Sydney, New South Wales
- Founded
- 2014
- Website
- https://www.vexev.com/
About Vexev
Vexev builds autonomous vascular-imaging systems around robotics, ultrasound and computational blood-flow analysis. Its lead platform, VxWave, guides an ultrasound probe and reconstructs three-dimensional vascular scans so trained non-specialist staff can acquire standardized images. The first clinical focus is upper-limb imaging for dialysis vascular access.
VxWave remains investigational and is not cleared for commercial sale. A multisite study with U.S. Renal Care reported a 94% scan-success rate in routine dialysis-clinic workflows. Vexev's August 2026 financing brings disclosed funding to $19 million and supports FDA 510(k) work, manufacturing scale-up and U.S. commercialization.
Market context
DEVELOPMENT
Summary
Type: Medical robotics company
Core: VxWave
Function: Automate vascular imaging
Audience: Dialysis clinics